MENU
PDSB
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
183.54M
112 days until earnings call
PDSB
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
183.54M
PDSB PDS Biotechnology Corp Chart, History Price & Graph
a developer of clinical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers
Industry Biotechnology
GET INTRADAY SIGNALS
A.I.Advisor
published price charts
View a ticker or compare two or three
VS
VS
PDSB and
Correlation & Price change
A.I.dvisor indicates that over the last year, PDSB has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PDSB jumps, then AXON could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To PDSB | 1D Price Change % | ||
|---|---|---|---|---|
| PDSB | 100% | -1.34% | ||
| AXON - PDSB | 43% Loosely correlated | +0.27% | ||
| MDGL - PDSB | 38% Loosely correlated | +0.54% | ||
| VCYT - PDSB | 36% Loosely correlated | +1.14% | ||
| VERA - PDSB | 35% Loosely correlated | +2.59% | ||
| ARRY - PDSB | 35% Loosely correlated | -1.86% | ||
More | ||||
Groups containing PDSB
Correlation & Price change
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To PDSB | 1D Price Change % |
|---|---|---|
| PDSB | 100% | -1.34% |
| cancer (undefined stocks) | 41% Loosely correlated | +0.20% |
| pharmaceuticals (undefined stocks) | 41% Loosely correlated | +0.92% |
| immunotherapy (undefined stocks) | 18% Poorly correlated | +2.25% |